Subscribe to RSS
DOI: 10.1055/s-0041-1737911
Synthesis of Phosphoramidate Prodrugs of Phenolic Natural Products and Drugs by Ester Exchange
Supported from the National Natural Science Foundation of China (91856126, 21778042), Scientific Research Grant of Ningbo University (215-432000282), and Ningbo Top Talent Project (215-432094250).
Abstract
Drug development based on phenolic natural products as drug candidates against various diseases has gained much attention in recent years. However, most of those molecules lack therapeutic efficacy in clinical trials, usually due to poor bioavailability. Therefore, a prodrug approach was adopted to address the bioavailability problem of phenolic drugs. This paper describes a mild and convenient method for late-stage ProTide-type prodrug synthesis of phenolic pharmaceuticals, which gives various phosphoramidate prodrugs from unprotected phenolic natural products and drugs in high yield. More importantly, this reaction is amenable for the selective phosphorylation of the phenolic hydroxyl group in the presence of otherwise problematic nucleophilic functional groups like amines and alcohols. We also observed that the chemical release rate of the phenol can be substantially tuned by changing the amino acid residue on the phosphoramidate moiety.
Key words
ProTide technology - prodrugs - phenolic drugs - phosphorylation - drug release - phosphoramidatesSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0041-1737911.
- Supporting Information
Publication History
Received: 11 January 2022
Accepted after revision: 14 February 2022
Article published online:
30 March 2022
© 2022. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Cheynier V, Comte G, Davies KM, Lattanzio V, Martens S. Plant Physiol. Biochem. 2013; 72: 1
- 2 González S, Fernández M, Cuervo A, Lasheras C. J. Hum. Nutr. Diet. 2014; 27: 176
- 3 Archivio M, Filesi C, Varì R, Scazzocchio B, Masella R. Int. J. Mol. Sci. 2010; 11: 1321
- 4 Férriz JM, Vinsová J. Curr. Pharm. Des. 2010; 16: 2033
- 5a Aungst BJ, Myers MJ, Shefter E, Shami EG. Int. J. Pharm. 1987; 38: 199
- 5b Trapani G, Latrofa A, Franco M, Lopedota A, Maciocco E, Liso G. Int. J. Pharm. 1998; 175: 195
- 5c Orienti I, Zuccari G, Bergamante V, Carosio R, Gotti R, Cilli M. Biomacromolecules 2007; 8: 3258
- 5d Garashi Y, Yanagisawa E, Ohshima T, Takeda S, Aburada M, Miyamoto KI. Chem. Pharm. Bull. 2007; 55: 328
- 5e Kim MK, Park K.-s, Yeo W.-s, Choo H, Chong Y. Bioorg. Med. Chem. 2009; 17: 1164
- 6a Leppänen JM, Huuskonen J, Savolainen J, Nevalainen T, Taipale H, Vepsalainen J. Bioorg. Med. Chem. Lett. 2000; 10: 1967
- 6b Baker WR, Cai S, Dimitroff M, Fang L, Huh KK, Ryckman DR. J. Med. Chem. 2004; 47: 4693
- 7a Cahard D, McGuigan C, Balzarini J. Mini-Rev. Med. Chem. 2004; 4: 371
- 7b Mehellou Y, Rattan HS, Balzarini J. J. Med. Chem. 2018; 61: 2211
- 7c Alanazi AS, James E, Mehellou Y. ACS Med. Chem. Lett. 2019; 10: 2
- 7d Serpi M, Pertusati F. Expert Opin. Drug Discovery 2021; 16: 1149
- 8a Slusarczyk M, Lopez MH, Balzarini J, Mason M, Jiang WG, Blagden S, Thompson E, Ghazaly E, McGuigan C. J. Med. Chem. 2014; 57: 1531
- 8b Slusarczyk M, Serpi M, Ghazaly E, Kariuki BM, McGuigan C, Pepper C. J. Med. Chem. 2021; 64: 8179
- 9 McGuigan C, Murziani P, Slusarczyk M, Gonczy B, Vande Voorde J, Liekens S, Balzarini J. J. Med. Chem. 2011; 54: 7247
- 10a McGuigan C, Serpi M, Bibbo R, Roberts H, Hughes C, Caterson B, Gibert AT, Verson CR. A. J. Med. Chem. 2008; 51: 5807
- 10b Serpi M, Bibbo R, Rat S, Roberts H, Hughes C, Caterson B, Alcaraz MJ, Gibert AT, Verson CR. A, McGuigan C. J. Med. Chem. 2012; 55: 4629
- 10c Hamon N, Quintiliani M, Balzarini J, McGuigan C. Bioorg. Med. Chem. Lett. 2013; 23: 2555
- 10d Hamon N, Slusarczyk M, Serpi M, Balzarini J, McGuigan C. Bioorg. Med. Chem. 2015; 23: 829
- 10e James E, Pertusati F, Brancale A, McGuigan C. Bioorg. Med. Chem. Lett. 2017; 27: 1371
- 10f Osgerby L, Lai Y.-C, Thornton PJ, Amalfitano J, Le Duff CS, Jabeen I, Kadri H, Miccoli A, Tucker JH. R, Muqit MM. K, Mehellou Y. J. Med. Chem. 2017; 60: 3518
- 10g Davey MS, Malde R, Mykura RC, Baker AT, Taher TE, Le Duff CS, Willcox BE, Mehellou Y. J. Med. Chem. 2018; 61: 2111
- 11 Wei Y, Qiu G, Lei B, Qin L, Chu H, Lu Y, Zhu G, Gao Q, Huang Q, Qian G, Liao P, Luo X, Zhang X, Zhang C, Li Y, Zheng S, Yu Y, Tang P, Ni J, Yan P, Zhou Y, Li P, Huang X, Gong A, Liu J. J. Med. Chem. 2017; 60: 8580
- 12 Kozak W, Rachon J, Daśko M, Demkowicz S. Asian J. Org. Chem. 2018; 7: 314
- 13 Procházková E, Navrátil R, Janeba Z, Roithová J, Baszczyňski O. Org. Biomol. Chem. 2019; 17: 315
Ester prodrugs:
Carbonate prodrugs:
Carbamate prodrugs: